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Abstract 
Introduction: Ascites is a common complication of advanced malignancies and cirrhosis. Symptoms 
of marked abdominal distention, shortness of breath, diminished appetite, fatigue, and lower-extremity 
edema can significantly compromise a patient’s everyday life. Treatment options for intractable ascites 
include serial paracentesis, peritoneovenous shunting, transjugular intrahepatic portosystemic shunt 
(TIPS) creation, and tunneled peritoneal catheters that may be external or, more recently, attached to 
subcutaneous ports. It is therefore appropriate to evaluate a port specifically designed for peritoneal 
access as a mean of controlling intractable ascites. We present a minimally invasive treatment for 
palliative drainage of symptomatic ascites in patients with advanced malignancy. 
 
Aim of the work: The aim of this work is to evaluate the percutaneous implantable access system 
specifically  designed  for  peritoneal  access  as  a  method  to  control  intractable  ascites  as  regards 
complications and patency. 
 
Methods: This is a prospective intervention study will be conducted on 40 patients with intractable 
ascites  referred  from  the  oncology  clinic  to  the  diagnostic  imaging  department  for  percutaneous 
placement of peritoneal portcath as a palliative treatment for the patient. 
 
Results: Good technical success rate (100%) in insertion was found with removal of ascites gradually. 
Immediate relief of symptoms (100%). There were no major complications. There was one minor 
complication(2.5%), a leakage at the port placement site in a patient with pancreatic carcinoma. The 
leakage  stopped  spontaneous  with  removal  of  ascites  and  the  patient  underwent  conservative 
management. 
 
Conclusion: peritoneal port systems for treatment intractable ascites is efficient way to avoid 
ascites related morbidity with increases patient compliance, satisfaction by decreased hospital visits as 
the drainage and patients monitor can be done in their homes. Port aspiration can be performed in 
some cases by patients or family members without nursing assistance. In comparison with tunneled 
peritoneal catheters with external components, the complication rate appears to be minimal. 
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INTRODUCTION 
Ascites  is  a  common  complication  of 
advanced malignancies and cirrhosis (1, 2&3). 
Symptoms  of  marked  abdominal  distention, 
shortness  of  breath,  diminished  appetite, 
fatigue,  and  lower-extremity  edema  can 
significantly compromise a patient’s everyday 
function (2).  
Available  treatment  options  for 
intractable  ascites  include  repeated 
paracentesis,  transjugular  intrahepatic 
portosystemic  shunt  (TIPS)  creation, 
peritoneovenous shunting, liver transplantation 
and tunneled peritoneal catheters with external 
component  yet  recently  peritoneal  port 
represent  minimally  invasive  effective  option 
for treatment of intractable ascites..  
Previously,  permanent  drainage 
catheters  with  external  component  was  not  
considered  viable  treatment  options  for 
intractable ascites as a result of problems with 
infection, malposition, and occlusion (4,5).  
However,  tunneled  peritoneal  catheters 
have been used for many years for peritoneal 
dialysis  with  acceptable  complication  rates 
(6,7).  In  1999,  27,000  people  received 
peritoneal  dialysis  in  the  United  States, 
constituting  9%  of  the  dialysis  population, 
where mortality rates was similar to or lower 
than  those  in  hemodialysis  patients  (8). 
Tunneled catheters have generally been placed 
in  operating  rooms  (6).  Recently,  2-year 
catheter  survival  rates  with  percutaneous 
placement have been reported to be 49%–82% 
(8). Rosenblum et al (4) described the use of a 
subcutaneous  venous  access  port  to  treat Role of Peritoneal Ports for Treatment of Intractable Ascites 
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refractory  ascites  with  promising  results  in 
nine patients.  
 
 
THE AIM OF THE WORK 
The  aim  of  this  work  is  to  evaluate  the 
percutaneous  implantable  access  system 
specifically designed for peritoneal access as a 
method to control intractable ascites as regards 
complications and patency. 
METHODS 
This is a prospective intervention study will be 
conducted  on  40  patients  with  intractable 
ascites at Ain Shams University Hospitals and 
some private clinics. Patients with intractable 
ascites are referred from the oncology clinic to 
the  diagnostic  imaging  department  for 
percutaneous placement of peritoneal portcath 
as  a  palliative  treatment  for  the  patient. 
Patients included in our study will be selected 
from them with the following criteria: 
International normalizing ratio (INR) less than 
1.5 
Prothrombin time should be less than 15 sec 
Partial  thromboplastin  time  should  be  near 
normal. 
Platelet  count  should  be  greater  than  50,000 
per mm3 to limit the risk of bleeding. 
There should be no infection at the time of port 
placement. 
At least a moderate amount of ascites should 
be present at the time of port placement to help 
insure placement of the catheter in an optimal 
location. 
No age predilection. 
And  we  will  exclude  those  patients  with 
infected ascites. 
The standard procedure that the patients would 
have is as follows: 
Patients  will  lie  supine,  after  the  surgical 
preparation,  an  18-gauge  needle  is  used  to 
access  the  ascites  under  ultrasound  guidance 
usually  at  the  right  iliac  region.  After 
spontaneous drainage of uncomplicated ascites 
is confirmed, a 0.035-inch-diameter guide wire 
is  introduced  through  the  needle  into  the 
ascites. A 16-F peel-away sheath is introduced 
over the guide wire into the peritoneal cavity. 
The  dilator  and  wire  are  removed  then  the 
catheter  is  then  advanced  through  the  peel-
away sheath into the ascites and the peel-away 
sheath is removed. The port pocket is usually 
created  over  the  anterolateral  lower  ribs.  A 
subcutaneous  tunnel  is  created  between  the 
pocket and the ascites entrance site with use of 
a  metal  tunneler.  The  port  is  placed  in  the 
pocket  and  then  the  skin  us  sutured  in  two 
layers skin and subcutaneous. (1) 
The  port  is  accessed  with  a  19-gauge  Huber 
needle and port aspiration is then performed to 
remove the remainder of the ascites. The port 
is  then  flushed  with  20  mL  of  heparinized 
saline solution (100 IU/mL). A sterile dressing 
is applied.  
 
The  selected  patients  who  had  approved  to 
participate  in  our  study  gave  an  informed 
consent  (or  their  guardians  approved)  their 
images will be included.  
 
RESULTS 
Our study is performed with the participation 
of 40 patients between October 2010 and 
March 2013. 25 0f them are males and 15 
female. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (4.1) shows sex distribution among our patient sample 
 
Male patients with mean age of 60.2 year; 5 patients cancer colon, 5 patients mesothelioma, 5 patients 
cancer head of pancreas,  4 patients bronchogenic carcinoma, 3 patients cancer sigmoid and 3 patients 
cancer stomach. 
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Figure (4.2) shows type of malignancy among our   male patient sample 
 
Female  patients  with  mean  age  of  54.5,  3  patients  cancer  stomach,  3  patients  cancer  sigmoid,  3 
patients cancer ovary, 1 patients liomyosarcoma, 1 patients mesothelioma, 1 patients adenosarcoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (4.3) shows type of malignancy among our female patient sample 
 
Data were collected and evaluated as regard the following points:-. 
  
Procedural data included (immediate results): Technical success of port placement, Removal of 
ascites, Symptom relief, and immediate complications. 
Long-term follow-up data included (long term results): Duration of symptom relief, Requirement 
for port removal, Duration of port patency, location where port aspiration was performed (hospital 
visits), and long term Complications 
 
Immediate Results 
 
Forty ports were placed in 40 patients all show technical success in insertion with removal of 
ascites gradually. Immediate relief of symptoms. There were no major complications. There was one 
minor complication, a leakage at the port placement site in a patient with pancreatic carcinoma. The 
leakage  stopped  spontaneous  with  removal  of  ascites  and  the  patient  underwent  conservative 
management. 
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Figure (4.4) shows short term results 
 
Long-term Results 
Thirty nine patients (97.5%) showed complete relief of symptoms and good compliance until 
death (the ports were still in place and functioning at the time of death) or the end of this study. 
Thirty nine patients (97.5%) were treated successfully without further catheter manipulation 
(catheter removal), antibiotic therapy.  
One patient (2.5%) had a clinical failure. She had her port successfully inserted (technical 
success) followed by immediate relief of symptoms and decreased hospital visits yet three month later 
she developed infection at port site and Loculation of ascites. Ascites sampling, culture and sensitivity 
was done where E-coli single growth was discovered. Cather removal and aggressive antibiotic were 
prescribed afterward infection subsided with no reaccumulation of ascites till the end of this study.  
The long-term patency rate of ports was 100% with mean patency duration 284.5 days. Forty 
patients are treated with peritoneal port without any occlusion that did not respond to a 20-mL saline 
solution flush even with kinking and migration of the catheter.  
Twenty eight patients died during the course of the study, due to severity of their underlying 
disease. Among them, the patency rate was 100%, with complete relief of symptoms in all.  
Twelve patients are still alive till the end of the study with patency rate 100%, and all had 
complete relief of symptoms caused by ascites.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (4.5) shows long term results. 
Thirty patients (75%) were treated at home (with decreased hospital visits) and five (12.5%) were 
treated as outpatients in our clinic because they were not able to use the device. Five patients (12.5%) were 
admitted  in  the  hospital  because  of  other  medical  problems  yet  avoidance  of  repeated  paracentesis  was 
satisfactory to patient and clinician. 
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Figure (4.6) shows hospital visit distribution. 
 
DISCUSSION 
Intractable  large-volume  ascites  is 
often  disabling  and  decreases  quality  of  life. 
Intractable ascites may be due to cirrhotic liver 
or  malignant  ascites.  The  malignant  type  can 
be  secondary  to  peritoneal  carcinomatosis, 
lymphangitic  carcinomatosis,  or  massive 
hepatic  metastases  and  frequently 
compromises  the  patients’  quality  of  life. 
Control  of  intractable  ascites  and  related 
symptoms remains a medical problem. (9) 
 
Currently  available  treatments  include 
repeted  paracentesis,  TIPS  creation,  and 
tunneled  peritoneal  catheters.  Some  of  the 
previously  listed  techniques  are  invasive  and 
require  general  anesthesia.  Other  raises  the 
need of repeated hospital visits. So they were 
not satisfactory to patient population in which 
palliation is the primary concern. (3) 
 
Tunneled  percutaneously  placed 
peritoneal ports series  were first described  by 
Rosenblum et al. (4).  
 
In  our  study  we  used  the  retrograde 
technique as we assumed that it is much easier 
in placing the catheter in good pelvic position 
allowing  better  drainage.  Yet  previously 
reported studies used other techniques with no 
reported  technique  related  complications, 
difficulties or failure.  
 
The ports used by Rosenblum (4) were 
modified  venous  access  ports  which  reports 
one  case  of  catheter  obstruction  (10%  of 
catheters).  In  the  study  performed  by  Ozkan 
(9)  and  in  our  study  we  used  peritoneal  port 
specifically designed to permit repeated access 
to  the  peritoneal  cavity.  Compared  with  the 
device used by Rosenblum et al, this catheter is 
larger  in  caliber  and  has  multiple  precut  side 
holes. These properties may explain the 100% 
patency rate in both studies. 
 
Rosenblum  (4)  in  his  study  nine 
patients  with  cirrhotic  refractory  ascites  were 
treated with 10 ports. There were three cases of 
bacterial  peritonitis  (33%  of  patients).  Ozkan 
(9) in his study seven patients with malignant 
refractory ascites. There was no reported cases 
bacterial peritonitis. In our  study we had  low 
infection  rate  only  one  case  representing  2.5 
%.  This  case  of  infection  occurred  3  month 
after  port  was  successfully  inserted  and  used 
for  3  month.  Infection  was  attributed  to  in 
ability  of  the  patient  to  use  the  port  under 
aseptic condition. Possible explanation for the 
low infection  rate in Ozkan study and in our 
study is that the patients had malignant ascites 
as  cirrhotic  patient  were  excluded  due  to  the 
fact  that  the  rate  of  spontaneous  bacterial 
peritonitis  in  these  patient  is  33%  rate  in  the 
report of Rosenblum et al (4). 
 
Rosenblum et al (4) reported that two 
of  three  cases  of  peritonitis  were  associated 
with  peritoneal  fluid  leakage  at  the  port  site. 
They  suggested  that  these  infections  could 
have  been  prevented  with  improved  suture 
technique  with  use  of  more  closely  spaced 
sutures  and  that  late  suture  removal  10–14 
days  after  port  placement  was  beneficial  for Role of Peritoneal Ports for Treatment of Intractable Ascites 
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further wound healing.  In our study adequate 
care  to  these  suture  details  may  be  another 
explanation of the lower infection rate (2.5 %) 
in this study. 
 
Previously  port  pocket  was  created 
related to the anterior superior iliac spin (4). In 
Ozkan (9) study placement of the port over a 
bony  surface  (lower  costal  margin)  yet 
reservoir  reversed  on  the  first  day  of  the 
procedure due to the large pocket size and not 
suturing the port. In our study we also used the 
lower costal margin as port site with especial 
care to port size and suturing the port would 
explain absence of reservoir reversal as minor 
procedural complication.  
 
The use of larger port size appears to 
provide an easier target for nurses to access the 
port and more easier for the patient to access 
port at home with decreased hospital visits and 
complication rate.  
 
In this study, the technical success rate 
was 100%, and in  the long term, the  patency 
rate  was  100%,  success  rate  without 
complications  was  97.5%,  and  complication 
rate was 2.5%. 
 
 
 
Case (1) 
This 65 years old female patient with metastatic cancer stomach. Clinical examination and radiological 
studies were done. US revealed clear tens ascites. 
 
   
Figure (8): radiograph shows  
Port-catheter catheter in place. 
Figure  (9):  3  D  reconstructed  CT  shows  port-
catheter catheter in place. Haytham M Nasser et al  
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Case (2): 
 
This 62 years old male patient with cancer head of pancrease. Clinical examination and radiological 
studies were done. US revealed clear tens ascites. 
 
 
Figure (10): 3 D reconstructed CT  
Shows port-catheter catheter in place. 
 
 
CONCLUSION 
Peritoneal  port  systems  for  intractable 
ascites is efficient way to avoid morbidity and 
the patient's  anxiety  related to  marked  ascites 
and repeated puncture-aspiration. Compared to 
chronic  indwelling  catheters,  subcutaneous 
location  of  port  system  provide  a  closed 
system  between  tapping  sessions  where  it 
allows an entire integration with total liberty in 
daily  life  between  two  sessions  of  drainage. 
Drainage  can  be  performed  in  an  outpatient 
basis. This patient-friendly technique may be a 
treatment  option  with  good  success  rate, 
patient compliance and clinician satisfaction. 
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Figure (8): radiograph shows port-
catheter catheter in place. 